Subscribe to Newsletter
Subspecialties Oncology

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

sponsored by Akoya Biosciences

Register here

December 1, 2022 - 15:00 GMT

This webinar will discuss the integrated use of pan-cancer gene expression analysis with Akoya Bioscience’s multiplexed immunofluorescence workflow on NMIBC FFPE tissues to find a predictive biomarker panel capable of stratifying patients who will benefit from BCG immunotherapy and to identify new targets for further investigation of therapeutic strategies for BCG-unresponsive tumours.

Register here

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine